POLR3A expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 8.81259509810661E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.95430000019081E-07 |
Normal-vs-Stage2 |
2.37270000003065E-06 |
Normal-vs-Stage3 |
1.35970124048868E-11 |
Normal-vs-Stage4 |
2.97799999993131E-07 |
Stage1-vs-Stage2 |
1.291370E-01 |
Stage1-vs-Stage3 |
1.081880E-03 |
Stage1-vs-Stage4 |
8.041600E-02 |
Stage2-vs-Stage3 |
4.010000E-01 |
Stage2-vs-Stage4 |
9.870400E-01 |
Stage3-vs-Stage4 |
3.685400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
8.28299651089992E-11 |
Normal-vs-AfricanAmerican |
2.18549999999595E-05 |
Normal-vs-Asian |
8.851000E-01 |
Caucasian-vs-AfricanAmerican |
7.610000E-01 |
Caucasian-vs-Asian |
3.731800E-02 |
AfricanAmerican-vs-Asian |
5.632400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
9.52948830956757E-12 |
Normal-vs-Female |
6.98569999957321E-07 |
Male-vs-Female |
3.390100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.743200E-03 |
Normal-vs-Age(41-60Yrs) |
1.98899999803714E-08 |
Normal-vs-Age(61-80Yrs) |
2.61680010993359E-10 |
Normal-vs-Age(81-100Yrs) |
8.17109999995402E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.357400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.706600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.548600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.829800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.234410E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.120800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.517400E-01 |
Normal-vs-Grade 2 |
2.16929999963256E-07 |
Normal-vs-Grade 3 |
1.50000012411056E-11 |
Normal-vs-Grade 4 |
9.10920000540827E-08 |
Grade 1-vs-Grade 2 |
6.034500E-02 |
Grade 1-vs-Grade 3 |
7.559400E-03 |
Grade 1-vs-Grade 4 |
1.351500E-02 |
Grade 2-vs-Grade 3 |
2.092000E-02 |
Grade 2-vs-Grade 4 |
5.753500E-02 |
Grade 3-vs-Grade 4 |
7.964400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
6.13340000010787E-07 |
Normal-vs-ccB subtype |
5.29880028743435E-10 |
ccA subtype-vs-ccB subtype |
3.867700E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.90309998263183E-09 |
Normal-vs-N1 |
1.364970E-01 |
N0-vs-N1 |
7.456800E-01 |
|
|